DENVER, August 1 /PRNewswire/ --

- Accretive U.S. 'Tuck-in' Purchase Adds Fully Integrated Web-Based Donor 
Recruitment System to Suite of Products

- 13th Specialized Software Application for Donor Centers and Hospitals
Worldwide

Global Med Technologies(R), Inc. ("Global Med" or the "Company") (OTC
Bulletin Board: GLOB), an international e-Health, medical information
technology company, today announced that it has executed an Asset Purchase
Agreement and closed a transaction with eDonor, located in Phoenix, Arizona,
for US$5 million. This acquisition is expected to be accretive immediately on
a fully diluted basis, net of financing costs. The transaction consists of
US$3.5 million in cash and US$1.5 million in Global Med common stock. eDonor
is a web-based donor relationship management system that integrates
recruitment, scheduling, retention and fulfillment for national as well as
local community blood centers. The acquisition is designed to complement
Global Med's strong line of international blood management and laboratory
information software and service solutions.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)

Dr. Mick Ruxin, Chairman and CEO of Global Med Technologies, Inc.,
commented, "Global Med's vision is to provide comprehensive solutions for the
blood management software industry. We realize that effective donor
recruitment is strategically important to our customers. eDonor's significant
market share and their innovative solutions make this acquisition a logical
next step in our evolution. We feel strongly that eDonor will benefit both
existing and new blood bank customers of Global Med's Wyndgate
Technologies(R) division and Global Med's recent international acquisition of
Inlog, SA." Dr. Ruxin continued, "With the eDonor acquisition, Global Med
will now have 13 software applications specifically geared toward donor
centers and hospitals."

The eDonor application has evolved to become the donor industry's premier
technology platform for donor recruitment, scheduling and retention.
Community blood centers view recruitment and retention of quality donor pools
as a priority to meet local transfusion needs. Among eDonor's notable U.S.
clients are the American Red Cross, Blood Systems, Inc. (BSI) Blood
Centers/Testing Facilities, the Institute for Transfusion Medicine, Florida's
Blood Centers, Lockheed/Armed Services Blood Program, and the Blood and
Tissue Center of Central Texas. Global Med's European software subsidiary,
Inlog, SA, will be a key driver to introducing eDonor's effective donor
relationship management system internationally.

Thomas F. Marcinek, President and COO of Global Med Technologies, Inc.,
stated, "Acquiring a proven, profitable and well-established market leader in
donor recruitment reduces the risk of product development and accelerates our
time to market. With eDonor, we can now deliver a turn-key, fully integrated
suite of products that eliminates the complexity and risk of integration
while lowering the total cost of ownership. We have great respect for the
management team of eDonor and their many accomplishments and look forward to
our combined synergies. This is truly a win-win for Global Med, eDonor, our
employees, our combined customer base and the industry."

The primary components of eDonor's product line unite flexible list
management tools with multiple communication channels to increase donor
retention and donation frequency. In addition, eDonor can automate manual
recruitment and scheduling processes that improve productivity and lower
costs. eDonor also supports the development and deployment of sophisticated
donor loyalty programs which further enhance a blood center's relationship
with its donors. eDonor's audited revenues for 2007 were US$3.3 million and
their net profit was US$337,000. For more information about eDonor and its
products visit http://www.eDonor.com.

Michael N. Pandelakis, President and CEO of eDonor, commented, "We have
always admired Global Med -- not only for their success in the marketplace,
but also for their consistently solid reputation with their customers. While
the product and services fit was obvious and the synergies readily apparent,
it was the cultural fit that we believe will ensure a quick and seamless
integration. We feel honored to join this winning team and contribute our
efforts to serving our joint customer base."

About Global Med Technologies, Inc.

Global Med Technologies(R), Inc. is an international medical software
company which develops regulated and non-regulated software products and
services for the healthcare industry. As a leading provider of blood and
laboratory software applications and services, Global Med's products are
deployed in 20 countries and serve over 1,400 transfusion centers, blood
banks and laboratories.

Global Med's U.S. division, Wyndgate Technologies(R), provides
Vein-to-Vein(R) tracking through its Donor Doc(TM), SafeTrace(R),
SafeTrace Tx(R) and ElDorado Donor(TM) software products. Each year,
Wyndgate's products and services manage more than eight million blood
components, representing over 27% of the U.S. blood supply.

Global Med's European subsidiary, Inlog, SA, is a leading provider of
donor center and transfusion management systems as well as cellular therapy
software, laboratory information systems and quality assurance medical
software systems internationally. Inlog's products include EdgeBlood**,
EdgeTrack**, EdgeCell, EdgeLab and SAPA.

Global Med's U.S. subsidiary, PeopleMed(R), Inc., provides cost-effective
customized software validation, consulting and compliance solutions to
hospitals and donor centers.

For more information about Global Med's products and services, please
call +1-800-996-3428 or visit http://www.globalmedtech.com,
http://www.peoplemed.com, http://www.inlog.com and http://www.wyndgate.com.

**FDA 510(k) clearance required prior to sales in the U.S.

This news release may include statements that constitute forward-looking
statements, usually containing the words "believe," "estimate," "project,"
"expects" or similar expressions. These statements are made pursuant to the
safe harbor provisions of the Private Securities Litigation Reform Act of
1995. Forward-looking statements inherently involve risks and uncertainties
that could cause actual results to differ materially from the forward-looking
statements. By making these forward-looking statements, the Company
undertakes no obligation to update these statements for revisions or changes
after the date of this news release.

Web site: http://www.globalmedtech.com
              http://www.peoplemed.com
              http://www.inlog.com
              http://www.wyndgate.com